期刊
TRENDS IN MOLECULAR MEDICINE
卷 21, 期 5, 页码 271-273出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2015.02.008
关键词
FDA; stem cell clinics; federal regulations; marketing; United States
Scholarship on patients accessing unproven stem cell interventions is dominated by research addressing 'stem cell tourism' to such countries as China, India, Mexico, and the Ukraine. However, clinics marketing 'adipose-derived mesenchymal stem cell treatments' are proliferating across the USA. These businesses typically claim to operate in compliance with federal regulations, but careful review of their commercial practices suggests that such clinics are marketing unapproved and noncompliant biological drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据